Why Warren Buffett Bought These New Stocks
Warren Buffett bought two new stocks in Q1: General Motors (NYSE: GM), which is also held by Marc Lasry, Kevin Eng, and David Einhorn, and Viacom (NASDAQ: VIAB). We are buyers of both and explain why...
Hedge Fund - Fisher Asset Management
Ken Fisher Bio, Returns, Net Worth
Ken Fisher is the author of seven money management books, three of which are New York Times bestsellers. He's been writing the Portfolio Strategy column for Forbes for over 26 years, and he's the fourth-longest running columnist in Forbes' history. He's currently ranked #252 on the 2010 Forbes 400 list of richest Americans. He founded private investment firm Fisher Investments in 1979.
Ken Fisher is the author of seven money management books, three of which are New York Times bestsellers. He's been writing the Portfolio Strategy column for Forbes for over 26 years, and he's the fourth-longest running columnist in Forbes' history. He's currently ranked #252 on the 2010 Forbes 400 list of richest Americans. He founded private investment firm Fisher Investments in 1979.
In 2010, Forbes published an accounting of Fisher's stock picks made in his columns over the preceding 14 years. His stock picks beat the S&P 500 overall on average. Ken Fisher's picks lagged the S&P 500 in just three years within the last 14 years. His picks in 2009 outperformed the S&P 500 index by 24 percentage points. The outperformance in 2010 was 5 percentage points.
Fund Profile
Showing:
| Fund Name: | Fisher Asset Management |
| Manager | Ken Fisher |
| Portfolio Value | $33,499,431,000 |
| Change This QTR | +1.10% |
Top Holdings
Showing:
Sorted by:
| No. | Security | Ticker | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|---|
| 1.) | SPY | 6,873,463 | $862,620 | +9728% |
2.57% | |
| 2.) | Ishares Trust |
6,330,788 | $720,190 | +2% |
2.14% | |
| 3.) | JNJ | 10,192,184 | $668,403 | -5% |
1.99% | |
| 4.) | BASFY | 9,284,623 | $649,524 | -3% |
1.93% | |
| 5.) | EFA | 12,881,518 | $638,022 | +17413% |
1.9% | |
| 6.) | SI | 6,098,169 | $583,046 | -3% |
1.74% | |
| 7.) | Ishares Trust |
15,814,391 | $551,448 |  |
1.64% | |
| 8.) | NSRGY | 9,361,994 | $540,636 | -2% |
1.61% | |
| 9.) | SLB | 7,918,888 | $540,939 | -3% |
1.61% | |
| 10.) | ABT | 9,306,286 | $523,293 | -0% |
1.56% | |
| 11.) | ORCL | 20,143,443 | $516,679 | -2% |
1.54% | |
| 12.) | UN | 15,073,353 | $518,071 | -1% |
1.54% | |
| 13.) | GSK | 11,304,333 | $515,817 | -3% |
1.53% | |
| 14.) | BIDU | 4,344,368 | $505,989 | +2% |
1.51% | |
| 15.) | PPG | 5,899,437 | $492,544 | -6% |
1.47% | |
| 16.) | NOV | 6,954,514 | $472,837 | -1% |
1.41% | |
| 17.) | XOM | 5,604,034 | $474,998 | -22% |
1.41% | |
| 18.) | PFE | 21,777,642 | $471,268 | -1% |
1.4% | |
| 19.) | EMC | 21,524,264 | $463,633 | -2% |
1.38% | |
| 20.) | INTC | 19,111,785 | $463,461 | -2% |
1.38% |
News, Interviews and Investor Letters
Best European Pharma Stock
European pharma has not had a great run recently, but we think we’ve found a diamond in the rough. Novo Nordisk (NYSE:NVO) is a Danish pharmaceuticals company that specializes in treatments for diabetes...
Healthcare Stocks: 2 To Buy, 1 To Avoid
Investors traditionally think of healthcare stocks as being highly defensive, due to the old adage: medical care is always needed, even in a bad economy. In recent years, though, the sector has become...
4 Reasons To Buy Exxon Mobil $XOM
Exxon Mobil Corporation holds a significant position in the global oil & gas sector through their industry leading portfolio of resources, technology portfolio, and disciplined investment approach...
Donald Yacktman’s Top Five Picks
We generally follow hedge funds, but we also keep a close eye on successful mutual fund managers. Donald Yacktman has been very successful over the last decade. However, Donald Yacktman’s eponymous...
New Developments in Pharma Companies: $AZN $GSK $LLY
We have previously voiced concerns over the future of AstraZeneca (NYSE: AZN), in particular its lackluster pipeline (read more on high dividend pharma stocks). Based on the company’s situation, we...
Barry Rosenstein’s Top 10 Picks Returned 15% YTD
Shares of bookseller Barnes and Noble (BKS) jumped on news that Barry Rosenstein’s Jana Partners initiated a 12% stake in the company. The news, which was announced late April 20, caused Barnes and...
A Closer Look into Infant Formula Business
Often lumped into the defensive stock category, Nestlé (FRA: NESM) just announced an acquisition in a growth industry. It agreed to acquire Pfizer’s (NYSE: PFE) Nutrition business for $11.9 billion...
Wal-Mart Mexico: A Target for Hedge Fund Short Sellers
Wal-Mart Stores Inc. (WMT), the global retail store behemoth which generated more than $443 B in revenues last year, is expected to come under selling pressure today. According to CNBC, this may be due...
Is Bristol Myers A Good Investment?
Is Bristol Myers a good investment today? Like many other large-cap drug manufacturers, Bristol-Myers Squibb (BMY) is faced with patent expiration on key products and risks related to new drug development...
Billionaires’ Stock Picks Are Beating the Market Right Now
If you’ve been reading articles about hedge fund performance over the past three years, you’re probably thinking index funds are better options for investors. During the last quarter, an average hedge...
Is Wal-Mart A Good Investment?
Warren Buffett is the man. The Oracle of Omaha has been quoted and mirrored for decades. When he makes a call about a stock, the world sits up and listens, be it a long time bullish position in Coca-cola...
7 Stocks Billionaire Hedge Funders Are Crazy About
Insider Monkey tracks nearly 400 hedge fund managers and prominent investors. Thirty nine of these fund managers are billionaires. Nowadays readers have access to websites that track the daily changes...
Is EMC Corp A Good Stock To Buy?
EMC Corp (EMC) was the top provider of disk storage systems in the fourth quarter of 2011. According to research firm IDC, EMC has a market share of nearly 23%, followed by Hewlett-Packard Company (HPQ...
Best High Dividend Pharma Stocks
In an investor’s quest for yield, stocks in the pharmaceutical industry are a great place to look. In spite of the oft-talked about looming patent cliff, large pharmaceutical companies still have large...
